levocetirizine dihydrochloride
- Product NDC
- 45802-680
- 11-digit product format
- 458020680
- Labeler code
- 45802
- Product ID
- 45802-680_1a939b38-64a2-4238-816d-4c01075e5cbe
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Levocetirizine dihydrochloride
- Dosage form
- SOLUTION
- Route
- ORAL
- Labeler
- Padagis Israel Pharmaceuticals Ltd
- Application
- ANDA091263
- Marketing category
- ANDA
- Marketing start
- 2011-11-07
- Substance
- LEVOCETIRIZINE DIHYDROCHLORIDE
- Active strength
- .5 mg/mL
- Pharmacologic classes
- Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- levocetirizine dihydrochloride
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| LEVOCETIRIZINE DIHYDROCHLORIDE | .5 mg/mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | SOD6A38AGA |
| Rxcui | 855168 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 45802-680-28 | levocetirizine dihydrochloride | 148 mL in 1 BOTTLE | SOLUTION | 148 | | 18 |
DailyMed Socrata Ingredients#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 45802-680 | LEVOCETIRIZINE DIHYDROCHLORIDE SOLUTION [PADAGIS ISRAEL PHARMACEUTICALS LTD] | 16 | Current NDC, Legacy NDC, 1 package rows | 20221221_2965ef46-18db-4615-9dce-bfb0f0b3366a.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 45802-680-28 | 45802068028 | 148 mL in 1 BOTTLE (45802-680-28) | 148 ml | 2011-11-07 | 0000-00-00 | No | No | Current |